- Tytuł :
- Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
- Autorzy :
- Źródło :
- In The Lancet Oncology June 2019 20(6):849-861
-
Czasopismo naukowe